Eli Lilly Buys Centessa for $6.3B to Bolster Sleep Drugs Eli Lilly agreed to buy Centessa for $6.3bn on Mar 31, 2026, expanding its sleep-medicine pipeline and signaling continued program-focused M&A in pharma.

Eli Lilly Buys Centessa for $6.3B to Bolster Sleep Drugs: Eli Lilly agreed to buy Centessa for $6.3bn on Mar 31, 2026, expanding its sleep-medicine pipeline and signaling continued program-focused M&A in… 👈 Read full analysis #EliLilly #Centessa #PharmaMergers #SleepMedicine #HealthcareInnovation

Ireland's Mallinckrodt closes spinout, rebrands as Keenova Two new pharma companies - Keenova and Par Health - have now emerged from the merger of Mallinckrodt and Endo earlier this year

Two new pharma companies - Keenova and Par Health - have emerged from the merger of Mallinckrodt and Endo earlier this year. #PharmaMergers #LifeSciencesStrategy
pharmaphorum.com/news/ireland...